LG has introduced a novel 21.3-inch IPS monitor featuring a peak brightness of 1,100 nits and an unconventional aspect ratio of 4:5. The LG 21HQ613D monitor is tailored for specialized medical uses such as mammography, boasting a resolution of 2048 x 2560 pixels that accentuates its 4:5 aspect ratio.
FDA Approval and Connectivity
The newly launched LG 21HQ613D IPS monitor has received approval from the United States Food and Drug Administration (FDA) for its application as a medical device. This monitor offers video connectivity options through DisplayPort or DVI and succeeds the LG 21HQ513 model, which has a comparatively lower resolution. The preceding 21HQ513 monitor with a resolution of 1536 x 2048 is currently listed on eBay for $4,923. An eminent feature of the LG 21HQ613D is its remarkable brightness of 1,100 nits and a contrast ratio of 1800:1. Noteworthy specifications include a PPI value of 153.9 and support for various viewing modes.
Enhanced Features and Specifications
This advanced LG monitor facilitates the dimming of specific image areas while enhancing focus on others, boasting color space coverage of 100% (sRGB) and 72% of NTSC. These color capabilities align with its predecessor, the 21HQ513D. The monitor is equipped with a versatile stand that allows tilt, swivel, height, and pivot adjustments. Users can conveniently tailor essential settings using five customizable keys provided on the device. Additionally, the monitor comes with cables for its DP and DVI ports along with an external power brick.
Dimensions and Availability
Weighing 5.45kg without its stand, the LG 21HQ613D monitor measures 364.5 x 474.4 x 78mm in size. Although LG has not disclosed the pricing details for this model yet, it is anticipated to exceed the cost of the 21HQ513D model, retailing for around $5,000. The product is set to be released in the US and select European markets.
